USPTO serial 79263441
SOTOXA
Reviewed by CopyMark Law Group
- Filing date
- Status date
- Registration date
- Jul 14, 2020
- Examiner
- HOWARD, PARKER WALDRIP
- Law office
- Historical data usage
What this means
This registration is in, or will soon enter, a USPTO maintenance window. Missing a Section 8 or Section 9 filing can cancel the registration.
Need help with SOTOXA?
If you own this trademark, we can monitor new filings and help with USPTO deadlines. If you do not, we can file a new U.S. application.
Current trademark owner
Get help with this Renewal, set up monitoring, or talk with CopyMark.
Get Attorney Assistance for just $2,144*
Plus Government fees of $2,550
Not the owner?
File a new U.S. trademark application, or speak with our attorneys.
Owner
Attorney of record
The USPTO lists this attorney as the applicant's representative for correspondence on this application.
Michele H. Bowman
Michele H. Bowman Abbott Laboratories100 Abbott Park RoadAbbott Park, IL 60064United StatesGoods and services
| Class | Description | Status | First use |
|---|---|---|---|
| 001 | Diagnostic reagents and chemical reagents, not for medical purposes; immunodiagnostic reagents, not for medical purposes; buffer solutions, not for medical purposes; immunoassay test strips, not for medical purposes; drug testing kits comprising reagents and assays, not for medical purposes; drug testing kits comprised of diagnostic reagents and assays for testing body fluids, not for medical purposes; drug testing systems comprising reagents and assays, not for medical purposes; kits comprising reagents and assays for testing for the presence of analytes in biological fluids, other fluids and other matrices, not for medical purposes; kits comprising reagents and assays for collecting and testing oral fluid for the presence of drugs and drug metabolites, not for medical purposes | ACTIVE | — |
| 005 | Diagnostic reagents and chemical reagents, for medical purposes; medical diagnostic and immunodiagnostic reagents, for medical purposes; drug testing kits comprising reagents and assays, for medical purposes; drug testing kits comprised of diagnostic reagents and assays for testing body fluids, for medical purposes; drug testing systems comprising reagents and assays, for medical purposes; kits comprising reagents and assays for testing for the presence of analytes in biological fluids, other fluids and other matrices, for medical purposes; kits comprising reagents and assays for collecting and testing oral fluid for the presence of drugs and drug metabolites, for medical purposes | ACTIVE | — |
| 009 | Downloadable software for downloading, storing, managing, analyzing, reporting, and printing drug test data in the fields of fields of toxicology, forensics, and drug testing; downloadable mobile application software for reading, recording, sharing, reporting, maintaining, managing, monitoring and analyzing data and information in the fields of fields of toxicology, forensics, and drug testing; downloadable software for downloading, storing, managing, analyzing, reporting, and printing drug test data; battery chargers for use with drug testing systems; printers for sale as part of drug testing systems; forensic drug analyzer system consisting primarily of electronic chemical analyzers, not for medical purposes; electronic immunodiagnostic apparatus and instruments for the detection of drugs of abuse, not for medical purposes; electronic drug testing apparatus and instruments, not for medical purposes; drug testing systems comprising non-medical electronic testing apparatus not for medical purposes | ACTIVE | — |
| 010 | Medical apparatus and instruments, namely, analyzers for the screening of drugs; medical diagnostic and immunodiagnostic apparatus and instruments, namely, analyzers for the screening of drugs; drug testing analyzers for medical purposes; drug testing cartridges adapted for use with electronic medical testing analyzers for medical purposes; drug testing cartridges comprised of immunoassay test strips adapted for use with electronic medical testing analyzers for medical purposes; chromatographic immunoassay test cartridges adapted for use with electronic medical testing analyzers for medical purposes; drug testing systems comprising medical testing apparatus for medical purposes; medical drug testing kits comprising medical testing apparatus; kits comprising medical apparatus for testing for the presence of analytes in biological fluids, other fluids and other matrices, all for medical purposes; kits comprising medical apparatus for collecting and testing oral fluid for the presence of drugs and drug metabolites, for medical use | ACTIVE | — |
| 042 | Software as a service (SAAS) featuring software for scientific purposes for toxicology reporting in the fields of forensics and drug testing; software as a service (SAAS) featuring software for scientific purposes for facilitating testing and analysis in the fields of forensics and drug testing; hosting a website featuring online databases for the provision of information in the fields of toxicology, forensics, and drug testing; providing updates for software; laboratory toxicology services; laboratory drug testing services; design and development of computer software for use with medical and non-medical technology | ACTIVE | — |
| 044 | Medical drug testing services; medical toxicology services | ACTIVE | — |
Related trademarks
CopyMark links this record to cited §2(d) serials, the owner's other marks, Nice classes, similar mark names, and recently changed USPTO applications.
- Other trademarks owned by Alere Toxicology plc
- Other trademarks owned by Abbott Toxicology Limited
- Other trademarks owned by Alere Toxicology plc
- Other trademarks in Class 001
- Other trademarks in Class 005
- Other trademarks in Class 009
- Other trademarks in Class 010
- Other trademarks in Class 042
- Other trademarks in Class 044
- Similar marks named SOTOXA
- Recently changed USPTO trademarks
- Recently filed trademarks
- Browse all trademark records
Prosecution history
| Date | Code | Event | What it means |
|---|---|---|---|
| Sep 14, 2026 | PR75 | POST REGISTRATION ACTION MAILED - SEC. 71 & 15 | — |
| Sep 8, 2026 | APRE | CASE ASSIGNED TO POST REGISTRATION PARALEGAL | — |
| Jul 8, 2026 | ES75 | TEAS SECTION 71 & 15 RECEIVED | — |
| Jul 14, 2025 | REM3 | COURTESY REMINDER - SEC. 71 (6-YR) E-MAILED | — |
| Jan 3, 2025 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Jan 5, 2024 | NREP | NEW REPRESENTATIVE AT IB RECEIVED | — |
| Feb 12, 2021 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Nov 28, 2020 | FINO | FINAL DECISION TRANSACTION PROCESSED BY IB | — |
| Nov 6, 2020 | FICS | FINAL DISPOSITION NOTICE SENT TO IB | — |
| Nov 6, 2020 | FIMP | FINAL DISPOSITION PROCESSED | — |
| Oct 14, 2020 | FICR | FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB | — |
| Jul 14, 2020 | R.PR | REGISTERED-PRINCIPAL REGISTER | Your trademark is registered on the Principal Register — the strongest form of federal trademark protection. You may use the ® symbol for the covered goods and services. Maintenance filings (Section 8 and renewals) are required to keep the registration alive. |
| Apr 28, 2020 | NPUB | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED | — |
| Apr 28, 2020 | PUBO | PUBLISHED FOR OPPOSITION | Your mark was published in the USPTO Official Gazette for a 30-day opposition window. During that period, third parties who believe they would be harmed can file an opposition. If no opposition is filed, prosecution usually continues toward registration or a Notice of Allowance. |
| Apr 8, 2020 | NONP | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED | — |
| Mar 20, 2020 | CNSA | APPROVED FOR PUB - PRINCIPAL REGISTER | — |
| Mar 20, 2020 | XAEC | EXAMINER'S AMENDMENT ENTERED | — |
| Mar 20, 2020 | GNEN | NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED | — |
| Mar 20, 2020 | GNEA | EXAMINERS AMENDMENT E-MAILED | — |
| Mar 20, 2020 | CNEA | EXAMINERS AMENDMENT -WRITTEN | — |
| Mar 13, 2020 | TEME | TEAS/EMAIL CORRESPONDENCE ENTERED | — |
| Mar 13, 2020 | CRFA | CORRESPONDENCE RECEIVED IN LAW OFFICE | — |
| Mar 13, 2020 | ALIE | ASSIGNED TO LIE | — |
| Mar 9, 2020 | TROA | TEAS RESPONSE TO OFFICE ACTION RECEIVED | This event means the applicant filed a response to a USPTO Office Action — typically arguments, amendments, or evidence addressing the examiner's objections. The USPTO will review the response and either allow the mark to proceed or issue another action. |
| Sep 27, 2019 | RFNT | REFUSAL PROCESSED BY IB | — |
| Sep 9, 2019 | RFCS | NON-FINAL ACTION MAILED - REFUSAL SENT TO IB | — |
| Sep 9, 2019 | RFRR | REFUSAL PROCESSED BY MPU | — |
| Aug 22, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Aug 21, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Aug 19, 2019 | RFWR | NON-FINAL ACTION (IB REFUSAL) WITHDRAWN FOR REVIEW | — |
| Aug 1, 2019 | ADCH | CHANGE OF NAME/ADDRESS REC'D FROM IB | — |
| Jul 27, 2019 | RFCR | NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW | — |
| Jul 26, 2019 | CNRT | NON-FINAL ACTION WRITTEN | A non-final Office Action means the USPTO examining attorney has raised at least one issue with your trademark application but has not made a final decision. You usually have three months to respond with arguments, amendments, or evidence. Missing the deadline can abandon the application. |
| Jul 26, 2019 | MAFR | APPLICATION FILING RECEIPT MAILED | — |
| Jul 22, 2019 | DOCK | ASSIGNED TO EXAMINER | — |
| Jul 22, 2019 | NWOS | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED | — |
| Jul 18, 2019 | REPR | SN ASSIGNED FOR SECT 66A APPL FROM IB | — |